Evidence map›Paper›PMID 37191947›Full record

ArticleEMBO reports2023

Monocytes differentiate along two alternative pathways during sterile inflammation.

Javiera Villar, Léa Ouaknin, Adeline Cros, Elodie Segura

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Single-Cell RNA-seq Analysis Reveals Distinct Tumor and Immunosuppressive T-Cell Phenotypes in Patients with CLL Treated with Ibrutinib.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  2. Review
  3. Immune cells composition in the skin and subcutaneous adipose tissue of patients with systemic sclerosis.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Javiera VillarInstitut Curie, PSL Research University, INSERM, U932, Paris, France.ORCID 0000-0002-8581-4155
Léa OuakninInstitut Curie, PSL Research University, INSERM, U932, Paris, France.
Adeline CrosInstitut Curie, PSL Research University, INSERM, U932, Paris, France.
Elodie SeguraInstitut Curie, PSL Research University, INSERM, U932, Paris, France.ORCID 0000-0003-1795-1921
Inserm · FR

Funding

Agence Nationale de la Recherche (ANR) ANR-10-IDEX-0001-02Agence Nationale de la Recherche (ANR) ANR-10-LABX-0043Agence Nationale de la Recherche (ANR) ANR-17-CE15-0011-01EC|Horizon Europe|Excellent Science|HORIZON EUROPE Marie Sklodowska-Curie Actions (MSCA) 666003Fondation pour la Recherche Médicale (FRM) FDT202106013025Institut Curie CIC IGR-Curie 1428Institut National de la Santé et de la Recherche Médicale (INSERM)
6 · The paper itself

Abstract

During inflammation, monocytes differentiate within tissues into macrophages (mo-Mac) or dendritic cells (mo-DC). Whether these two populations derive from alternative differentiation pathways or represent different stages along a continuum remains unclear. Here, we address this question using temporal single-cell RNA sequencing in an in vitro model, allowing the simultaneous differentiation of human mo-Mac and mo-DC. We find divergent differentiation paths, with a fate decision occurring within the first 24 h and confirm this result in vivo using a mouse model of sterile peritonitis. Using a computational approach, we identify candidate transcription factors potentially involved in monocyte fate commitment. We demonstrate that IRF1 is necessary for mo-Mac differentiation, independently of its role in regulating transcription of interferon-stimulated genes. In addition, we describe the transcription factors ZNF366 and MAFF as regulators of mo-DC development. Our results indicate that mo-Macs and mo-DCs represent two alternative cell fates requiring distinct transcription factors for their differentiation.

Indexed as

Dendritic CellsMonocytesCell DifferentiationHumansInflammationMacrophagesTranscription FactorsTranscription Factorsdendritic cellsdifferentiationmacrophagesmonocytes

Identifiers

PMID37191947
PMCPMC10328069
OpenAlexW4376642769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.